These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 16240215

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Patient education series. Erectile dysfunction.
    Lewis JH, Rosen R, Goldstein I.
    Nursing; 2005 Feb; 35(2):64. PubMed ID: 15706284
    [No Abstract] [Full Text] [Related]

  • 3. How new drugs help treat erectile dysfunction.
    Weeks B, Ficorelli CT.
    Nursing; 2006 Jan; 36(1):18-9. PubMed ID: 16394991
    [No Abstract] [Full Text] [Related]

  • 4. Medication utilization behavior in patients receiving phosphodiesterase type 5 inhibitors for erectile dysfunction.
    Mulhall JP, McLaughlin TP, Harnett JP, Scott B, Burhani S, Russell D.
    J Sex Med; 2005 Nov; 2(6):848-55. PubMed ID: 16422809
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Differential effects of phosphodiesterase-5 inhibitors on hypoxic pulmonary vasoconstriction and pulmonary artery cytokine expression.
    Tsai BM, Turrentine MW, Sheridan BC, Wang M, Fiore AC, Brown JW, Meldrum DR.
    Ann Thorac Surg; 2006 Jan; 81(1):272-8. PubMed ID: 16368379
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. There have been inadequate warnings that erectile dysfunction drugs can cause blindness.
    Wolfe SM.
    MedGenMed; 2005 Dec 05; 7(4):61. PubMed ID: 16614683
    [No Abstract] [Full Text] [Related]

  • 10. Erectile dysfunction.
    Katz A, Katz A.
    CMAJ; 2010 Mar 09; 182(4):381-2. PubMed ID: 20142374
    [No Abstract] [Full Text] [Related]

  • 11. The phosphodiesterase inhibitor 'war'.
    Wyllie MG.
    BJU Int; 2003 Apr 09; 91(6):573-4. PubMed ID: 12656917
    [No Abstract] [Full Text] [Related]

  • 12. New phosphodiesterase type 5 inhibitors in the management of erectile dysfunction.
    Mason RG.
    J R Soc Promot Health; 2003 Jun 09; 123(2):79-80. PubMed ID: 12852189
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Clinical update on phosphodiesterase type-5 inhibitors for erectile dysfunction.
    Briganti A, Salonia A, Deho' F, Zanni G, Barbieri L, Rigatti P, Montorsi F.
    World J Urol; 2005 Dec 09; 23(6):374-84. PubMed ID: 16273417
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Towards optimal ED management: educational forum - II.
    Brock G.
    Can J Urol; 2001 Dec 09; 8(6):1419-20. PubMed ID: 11799971
    [No Abstract] [Full Text] [Related]

  • 18. Therapy of ED: PDE-5 Inhibitors.
    Shabsigh R.
    Endocrine; 2004 Dec 09; 23(2-3):135-41. PubMed ID: 15146092
    [Abstract] [Full Text] [Related]

  • 19. Phosphodiesterase-5 inhibitors: clinical market and basic science comparative studies.
    McCullough A.
    Curr Urol Rep; 2004 Dec 09; 5(6):451-9. PubMed ID: 15541215
    [Abstract] [Full Text] [Related]

  • 20. Erectile dysfunction and the drugs to treat it. In many cases, medications are all a man needs to stay sexually active.
    Harv Health Lett; 2014 May 09; 39(7):7. PubMed ID: 25073193
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.